IL-1? enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease.

Jalbert E, Crawford TQ, D'Antoni ML, Keating SM, Norris PJ, Nakamoto BK, Seto T, Parikh NI, Shikuma CM, Ndhlovu LC, Barbour JD. IL-1? enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease. PLoS One. 2013; 8(9):e75500.

View in: PubMed

subject areas

Anti-Retroviral Agents
Cardiovascular Diseases
Female
HIV Infections
HIV-1
Humans
Inflammation
Interleukin-1beta
Interleukin-6
Interleukin-8
Male
Middle Aged
Monocytes
Risk
Tumor Necrosis Factor-alpha

authors with profiles

Beau Nakamoto, MD
Cecilia M. Shikuma,MD
Todd B. Seto, MD
Lishomwa Ndhlovu, MD PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support